Toxicity Evaluation of Replication-Competent Herpes Simplex Virus (ICP 34.5 Null Mutant 1716) in Patients With Recurrent Malignant Glioma
Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301184
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2000
Authors
Publisher
Springer Science and Business Media LLC